Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fleischmann's Yeast, founded in 1868 by Charles Louis and Maximilian Fleischmann with James Gaff, revolutionized commercial yeast production in the United States. It introduced America’s first standardized commercial yeast product. The company has changed ownership several times—most recently acquired by Associated British Foods in 2004—and remains active as a leading brand of baker’s yeast for both consumer and industrial markets[6][8]. It does not develop therapeutics or health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fleischmann's Yeast.